US would broaden its fight against drug networks in the Middle East, including meth and Captagon.
This bill would update how the U.S. government plans to stop drug production and trafficking in the Middle East. It would expand the focus to include all drug networks in the region, moving beyond those linked to Syria's former Assad regime. The plan would specifically target Captagon, methamphetamine, and other amphetamines. The new plan would also be public and require detailed assessments of drug patterns and countries' ability to fight them.
Today, the U.S. has a strategy to fight drug networks in the Middle East, primarily focusing on those linked to the Assad regime in Syria. If this bill becomes law, the U.S. strategy would expand to target all drug networks across the Middle East, including methamphetamine and amphetamines, and would be a public, written plan with detailed assessments by the United States Central Command.
HR 7180 · 119th Congress · January 21, 2026 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
1 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.